Whitaker-Myers Wealth Managers’s Gilead Sciences GILD Stock Holding History

Whitaker-Myers Wealth Managers’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-18,284	Closed	-$2.31M	–	125
2026 Q2	$2.31M	Buy	18,284 +3,890	+27%	+$513K	0.39%	45
2026 Q1	$2.01M	Buy	+14,394	New	+$2.02M	0.4%	46

Other funds holding GILD

Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return

Stokes Capital Advisors Greenwood, South Carolina $455M AUM 9.69% 1-Year Est. Return

Whitaker-Myers Wealth Managers's GILD Position: Q3 2026 in Review

Whitaker-Myers Wealth Managers sold out of Gilead Sciences (GILD) in Q3 2026, closing a stake of 18,284 shares — an estimated $2.31M sold.

Whitaker-Myers Wealth Managers first reported a position in GILD in Q1 2026 and held it in 2 quarters. The position peaked at $2.31M in Q2 2026. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

Whitaker-Myers Wealth Managers reported no remaining Gilead Sciences position as of Q3 2026 after selling out during the quarter.
Whitaker-Myers Wealth Managers sold 18,284 Gilead Sciences shares in Q3 2026, an estimated $2.31M.
Whitaker-Myers Wealth Managers first reported a position in Gilead Sciences in Q1 2026 and held it in 2 quarters.
Whitaker-Myers Wealth Managers's Gilead Sciences position peaked at $2.31M in Q2 2026.
119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Whitaker-Myers Wealth Managers's 13F filing for Q3 2026, filed 9 Oct 2026.